Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors
The focus of this webinar will be on two aspects of integrative analysis and translational research in the field of estrogen receptor-positive (ER+) breast cancer research. Namely, Dr. Meenakshi Anurag will discuss the identification of protein drivers of endocrine therapy resistance in ER+ breast cancer through pathway-centric analysis. She will also dive into hypothesis validation of her research through Clinical Proteomic Tumor Analysis Consortium (CPTAC)-generated patient profiling data and establishment of the roles of driver and biomarker proteins associated with treatment response.
Dr. Meenakshi Anurag is an assistant professor at Baylor College of Medicine. Her primary research goal is to improve breast cancer diagnosis, treatment, and survival by precision data science.
- HLA Class II Across The Cancer Genome Atlas Cancer DatasetOctober 27, 2021Cloud Computing Workshop: Cancer Genomics Cloud (CGC)October 28, 2021Cloud Computing Workshop: FireCloudNovember 04, 2021NCI Childhood Cancer Data Initiative Annual Symposium 2021November 09, 2021